Drugs Made In America Acquisition (DMAA) Shares Issued (2025)
Drugs Made In America Acquisition (DMAA) reported Shares Issued of -$225.6 million for Q4 2025, down 200.0% quarter-over-quarter from $225.6 million in Q3 2025.
Drugs Made In America Acquisition (DMAA) Shares Issued (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Shares Issued for 1 years, with the latest figure at -$225.6 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued changed N/A year-over-year to -$225.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $3.2 million, up 9042.86% from the prior year.
- Shares Issued for Q4 2025 stood at -$225.6 million, down from $225.6 million in the prior quarter.
- The five-year high for Shares Issued was $228.8 million in Q1 2025, with the low at -$225.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | - |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | - |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 1.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | - |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | - |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | -225.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -225.65 Mn |
| Dec 31, 2025 | -225.65 Mn |
| Sep 30, 2025 | 225.65 Mn |
| Sep 30, 2025 | 225.65 Mn |
| Jun 30, 2025 | -225.65 Mn |
| Jun 30, 2025 | -225.65 Mn |
| Mar 31, 2025 | 228.85 Mn |
| Mar 31, 2025 | 228.85 Mn |